{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:51:51Z","timestamp":1794516711944,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.expneurol.2020.113534","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T20:53:29Z","timestamp":1606424009000},"page":"113534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia"],"prefix":"10.1016","volume":"336","author":[{"given":"Kathryn","family":"Lanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Centner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Del Priore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric P.","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.expneurol.2020.113534_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov Disord"},{"issue":"17","key":"10.1016\/j.expneurol.2020.113534_bb0010","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.0837-12.2012","article-title":"Galpha(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia","volume":"32","author":"Alcacer","year":"2012","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/mds.870120107","article-title":"Long-term changes of striatal dopamine D2 receptors in patients with Parkinson\u2019s disease: a study with positron emission tomography and [11C]raclopride","volume":"12","author":"Antonini","year":"1997","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.expneurol.2020.113534_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4939-3271-9_14","article-title":"Intraparenchymal stereotaxic delivery of rAAV and special considerations in vector handling","volume":"1382","author":"Benskey","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"15","key":"10.1016\/j.expneurol.2020.113534_bb0030","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1523\/JNEUROSCI.5884-08.2009","article-title":"Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia","volume":"29","author":"Berthet","year":"2009","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2020.113534_bb0035","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine d3 receptor function","volume":"9","author":"Bezard","year":"2003","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.expneurol.2020.113534_bb0040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.neuropharm.2005.03.008","article-title":"Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958","volume":"49","author":"Bishop","year":"2005","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.expneurol.2020.113534_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ymthe.2004.08.031","article-title":"Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion","volume":"11","author":"Burger","year":"2005","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.expneurol.2020.113534_bb0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2020.113534_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.017","article-title":"Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats","volume":"77","author":"Conti","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2020.113534_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2016.01.004","article-title":"Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats","volume":"142","author":"Conti","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2020.113534_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2014.01.011","article-title":"Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors","volume":"263","author":"Cote","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","article-title":"Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model","volume":"179","author":"Dekundy","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2020.113534_bb0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2018.09.018","article-title":"5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction","volume":"121","author":"Fanni","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.expneurol.2020.113534_bb0080","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s12035-014-8936-x","article-title":"Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia","volume":"52","author":"Farre","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28273-5","article-title":"Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats","volume":"8","author":"Fieblinger","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.expneurol.2020.113534_bb0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuron.2018.01.017","article-title":"A Subpopulation of Striatal Neurons Mediates Levodopa-Induced Dyskinesia","volume":"97","author":"Girasole","year":"2018","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.expneurol.2020.113534_bb0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1212\/WNL.52.4.771","article-title":"D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys","volume":"52","author":"Grondin","year":"1999","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.expneurol.2020.113534_bb0100","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.parkreldis.2004.11.005","article-title":"Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors","volume":"11","author":"Guigoni","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.expneurol.2020.113534_bb0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/mol.114.093096","article-title":"Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer","volume":"86","author":"Guitart","year":"2014","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.expneurol.2020.113534_bb0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25292","article-title":"The current and projected economic burden of Parkinson\u2019s disease in the United States","volume":"28","author":"Kowal","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2020.113534_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2018.06.024","article-title":"Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: implications for L-DOPA-induced dyskinesia","volume":"138","author":"Lanza","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-019-05353-6","article-title":"Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat","volume":"237","author":"Lanza","year":"2019","journal-title":"Psychopharmacology"},{"issue":"21","key":"10.1016\/j.expneurol.2020.113534_bb0125","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1523\/JNEUROSCI.1022-15.2015","article-title":"Incubation of methamphetamine craving is associated with selective increases in expression of Bdnf and trkb, glutamate receptors, and epigenetic enzymes in cue-activated fos-expressing dorsal striatal neurons","volume":"35","author":"Li","year":"2015","journal-title":"J Neurosci"},{"issue":"18","key":"10.1016\/j.expneurol.2020.113534_bb0130","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/bph.13937","article-title":"D-512, a novel dopamine D2\/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats","volume":"174","author":"Lindenbach","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2006.09.019","article-title":"The \u201cmotor complication syndrome\u201d in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration","volume":"177","author":"Lindgren","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113534_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"10.1016\/j.expneurol.2020.113534_bb0150","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.celrep.2019.09.076","article-title":"Functionally distinct connectivity of developmentally targeted striosome neurons","volume":"29","author":"McGregor","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2020.113534_bb5000","article-title":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"11","key":"10.1016\/j.expneurol.2020.113534_bb0155","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1523\/JNEUROSCI.2822-18.2018","article-title":"Ventral Pallidum Is the Primary Target for Accumbens D1 Projections Driving Cocaine Seeking","volume":"39","author":"Pardo-Garcia","year":"2019","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.expneurol.2020.113534_bb0160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/WNL.0000000000002285","article-title":"D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia","volume":"86","author":"Payer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2020.113534_bb0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nicl.2017.08.013","article-title":"Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson\u2019s patients","volume":"16","author":"Politis","year":"2017","journal-title":"Neuroimage Clin"},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/jpet.107.126219","article-title":"Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"323","author":"Putterman","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2010.08.018","article-title":"L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V\/VI and increased GABA release in the substantia nigra reticulata","volume":"41","author":"Rangel-Barajas","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.expneurol.2020.113534_bb0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2019.04.019","article-title":"Neonatal nicotine exposure primes midbrain neurons to a dopaminergic phenotype and increases adult drug consumption","volume":"86","author":"Romoli","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"14","key":"10.1016\/j.expneurol.2020.113534_bb0185","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1523\/JNEUROSCI.4997-14.2015","article-title":"Context-induced reinstatement of methamphetamine seeking is associated with unique molecular alterations in Fos-expressing dorsolateral striatum neurons","volume":"35","author":"Rubio","year":"2015","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.expneurol.2020.113534_bb0190","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.celrep.2018.05.059","article-title":"Aberrant striatal activity in parkinsonism and levodopa-induced dyskinesia","volume":"23","author":"Ryan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2020.113534_bb0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-4939-9065-8_6","article-title":"Multimodal production of Adeno-associated virus","volume":"1937","author":"Sandoval","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.expneurol.2020.113534_bb0200","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00702-018-1852-x","article-title":"Dopamine receptors: homomeric and heteromeric complexes in L-DOPA-induced dyskinesia","volume":"125","author":"Solis","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1","key":"10.1016\/j.expneurol.2020.113534_bb0205","first-page":"435","article-title":"Dopamine D3 receptor modulates l-DOPA-induced dyskinesia by targeting D1 receptor-mediated striatal Signaling","volume":"27","author":"Solis","year":"2017","journal-title":"Cereb. Cortex"},{"issue":"980","key":"10.1016\/j.expneurol.2020.113534_bb0210","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","article-title":"Levodopa-induced dyskinesia in Parkinson\u2019s disease: clinical features, pathogenesis, prevention and treatment","volume":"83","author":"Thanvi","year":"2007","journal-title":"Postgrad. Med. J."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620303654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620303654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:52:31Z","timestamp":1762149151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488620303654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":43,"alternative-id":["S0014488620303654"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113534","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113534"}}